Catalyst Crew Technologies Corp. (OTC: CCTC) announced today that it has established an operating presence in Venezuela through a wholly owned subsidiary, marking a key step in its strategy to expand digital health and artificial intelligence (AI) initiatives in Latin America. The company, which focuses on telehealth infrastructure and healthcare analytics for emerging markets, plans to deploy platforms including CardioAI, PulmoAI, and NeuroAI to support remote patient monitoring and AI-enabled diagnostics.
The new subsidiary will facilitate evaluation of market opportunities, development of strategic partnerships, and implementation of healthcare technology solutions. Management believes that a local entity is essential for pilot programs and collaboration with healthcare providers in the country. Dr. Kevin Rodan Levy, CEO of Catalyst Crew Technologies, stated that combining AI-driven technologies with localized infrastructure can support more accessible and efficient medical services.
Catalyst Crew Technologies intends to prioritize Latin America, where technology-enabled healthcare could expand access to medical services and improve diagnostic capabilities. The company’s AI platforms are designed to integrate into broader healthcare services as development progresses. For more information, visit https://catalystcrewai.com or review SEC filings at www.sec.gov.
The announcement underscores the company’s commitment to building an integrated healthcare technology platform for emerging markets. However, the company is a development-stage enterprise with no revenues from its new business direction, and there are risks associated with implementation, financing, and regulatory approvals. Prospective investors are urged to review risk factors in SEC filings before making investment decisions.
